Demographic and Histopathologic Study of Kaposi's Sarcoma in a Dermatology Clinic in the Years of 2006 to 2011

  • Kambiz Kamyab Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Amir Hooshang Ehsani Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Arghavan Azizpour Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Zahra Mehdizad Department of Medicine, Faculty of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Zeinab Aryanian Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Azadeh Goodarzi Mail Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Nessa Aghazadeh Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Pardis Hejazi Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Mehrnaz Salehi Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Zahra Seyedain Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Keywords:
Kaposi's sarcoma, Iran, Histopathology, Dermatology

Abstract

Kaposi's sarcoma is a low-grade vascular tumor that its prevalence is increasing all around the world due to the increasing prevalence of HIV and organ transplantations. In this study, we assessed risk factors of Kaposi's sarcoma among Iranian patients were referred to Dermatopathology Department of Razi Hospital of Tehran University of Medical Sciences between the years of 2006 to 2011. Also, disease stages have been assessed on pathologic specimens. Thirty four patients diagnosed with Kaposi's sarcoma entered the study. Of the 34 patients, 29% were female, and 71% were male, mean age was 66 years and average disease duration was 6 months. The most common patient's pathologic stages were reported: patch 32%, patch to plaque 24%, plaque 12%. The most prevalent location of involvement was lower extremity (88%), and upper extremity was involved in 24%. At presentation time, the mean number of lesions was 3 to 4. 15% of patients had a history of smoking and 15% had a history of immunosuppressive drugs. HIV infection did not observe in the patients. Based on the present study, Kaposi's sarcoma is a disease of elderly and is higher in older men. The most common site of Kaposi's sarcoma involvement is lower extremity, and the most common pathologic stage was the patch to plaque.

References

Lynen L, Zolfo M, Huyst V, et al. Management of Kaposi’s sarcoma in resource limited settings in the era of HAART. AIDS Res 2005;7(1):13-21.

Schwartz RA, Micali G, Nasca MR, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 2008;59(2):179-206.

Szajerka T, Jablecki J. Kaposi’s sarcoma revisited. AIDS Res 2007;9(4):230-6.

Schwartz RA. Kaposi’s sarcoma: an update. J Surg Oncol 2004;87(3):146-51.

Mohanna S, Bravo F, Ferrufino JC, et al. Classic Kaposi’s sarcoma presenting in the oral cavity of two HIV-negative Quechua patients. Med Oral Patol Oral Cir Bucal 2007;12(5):E365-8.

Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266(5192):1865-9.

Moore PS, Chang Y. Kaposi’s sarcoma (KS), KSassociated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 1998;147(3):217-21.

Grulich AE, Beral V, Swerdlow AJ. Kaposi’s sarcoma in England and Wales before the AIDS epidemic. Br J Cancer 1992;66(6):1135-7.

Hjalgrim H, Melbye M, Lecker S, et al. Epidemiology of classic Kaposi’s sarcoma in Denmark between 1970 and 1992. Cancer 1996;77(7):1373-8.

Geddes M, Franceschi S, Barchielli A, et al. Kaposi’s sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994;69(2):333-6.

Mousavi SM, Mohagheghi MA, Mousavi Jerrahi A. Epidemiology of Kaposi sarcoma in iran: 1984-2006. Asian Pac J Cancer Prev 2007;8(4):557-60.

Iscovich J, Boffetta P, Winkelmann R, et al. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS 1998;12(15):2067-72.

Dal Maso L, Polesel J, Ascoli V, et al. Classic Kaposi's sarcoma in Italy, 1985-1998 Cancer and AIDS Registry Linkage Study. Br J Cancer 2005;92(1):188-93.

Touloumi G, Kaklamanis L, Potouridou I, et al. The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 1997;70(5):538-41.

Hiatt KM, Nelson AM, Lichy JH, et al. Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIVrelated Kaposi Sarcoma patients with comparison to HIVrelated Kaposi Sarcoma. Mod Pathol 2008;21(5):572-82.

Vitale F, Briffa DV, Whitby D, et al. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 2001;91(4):588-91.

Chariyalertsak S, Sirisanthana T, Saengwonloey O, et al. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-- 1998: regional variation and temporal trends. Clin Infect Dis 2001;32(6):955-62.

Goedert JJ, Vitale F, Lauria Cet al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 2002;94(22):1712-8.

How to Cite
1.
Kamyab K, Ehsani AH, Azizpour A, Mehdizad Z, Aryanian Z, Goodarzi A, Aghazadeh N, Hejazi P, Salehi M, Seyedain Z. Demographic and Histopathologic Study of Kaposi’s Sarcoma in a Dermatology Clinic in the Years of 2006 to 2011. Acta Med Iran. 52(5):381-384.
Section
Articles